DNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptor.
Zhou H, Luo Y, Lo JF, Kaplan CD, Mizutani M, Mizutani N, Lee JD, Primus FJ, Becker JC, Xiang R, Reisfeld RA.
Zhou H, et al. Among authors: kaplan cd.
Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):10846-51. doi: 10.1073/pnas.0502208102. Epub 2005 Jul 22.
Proc Natl Acad Sci U S A. 2005.
PMID: 16040807
Free PMC article.